The Use of Anticholinergic Drugs for Smoking Cessation: A Pilot Study

References

• Birdsall N. J.M., Burgen A. S.V., Hulme E. C. Correlation between the binding properties and pharmacological responses of muscarinic receptors. Cholinergic Mechanisms and Psychopharmacology, D. J. Jenden. Plenum Press, New York 1978; Vol. 24: 25–33
   Google Scholar
• Brimblecombe R. W. Anticholinesterase agents. Drug Actions on Cholinergic Systems. University Park Press, Baltimore 1974; 94–95
   Google Scholar
• Cashin W. L., Brooks S. H., Blankenhorn D. H., Selzer R. H., Sanmarco M. E., Benjauthrit B. Computerized edge tracking and lesion measurement in coronary angiograms: A pilot study comparing smokers with non-smokers. Atherosclerosis 1984; 52: 295–300
   PubMed Web of Science ®Google Scholar
• Condiotte M. M., Lichtenstein E. Self-efficacy and relapse in smoking cessation programs. J. Consult. Clin. Psychol 1981; 49: 458–658
   Web of Science ®Google Scholar
• Corti C. A History of Smoking. Harcourt Brace, New York 1932
   Google Scholar
• Dahlstrom A., Booj S., Heiwall P. O., Larsson P. A. The effect of chronic nicotine and withdrawal on intra-neuronal dynamics of acetylcholine and related enzymes in a preganglionic neuron system of the rat. Acta Physiol. Scand 1980; 110: 13–20
   PubMedGoogle Scholar
• Eiser J. R., Sutton S. R. ‘Consonant’ and ‘dissonant’ smokers and the self-attribution of addiction. Addict. Behav 1978; 3: 99–106
   PubMed Web of Science ®Google Scholar
• Glick S. D., Jarvik M. E., Nakamura N. K. Inhibition by drugs of smoking behavior in monkeys. Nature August 29, 1970; 222: 969–971
   Google Scholar
• Goldstein A., Goldstein D. B. Enzyme expansion theory of drug tolerance and physical dependence. Proc. Assoc. Res. Ment. Dis 1968; 46: 265–267
   PubMedGoogle Scholar
• Grosz H. J. Nicotine addiction: Treatment with medical hypnosis. J. Indiana State Med. Assoc, Part 2. 1978; 72: 43–45, Part 3, 79, 43–45, 1979
   Google Scholar
• Hirschorn I. D., Rosecrans J. A. Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psy-chopharmacologia 1974; 40: 109–120
   PubMedGoogle Scholar
• Hunt W. A., Bespalec D. A. An evaluation of current methods of modifying smoking behavior. J. Clin. Psychol 1981; 27: 455–456
   Google Scholar
• Jarvik M. E. Biological influences on cigarette smoking. The Behavioral Aspects of Smoking, N. A. Krasnegor. NIDA Research Monographs 2.6. DHEW, U.S. Government Printing Office, Washington, DC 1979; 7–45
   Google Scholar
• Ketchum J. S., Sidell F. R., Crowell E. B., Jr., Aghajanian G. K., Hayes A. H., Jr. Atropine, scopolamine, and ditran: Comparative pharmacology and antagonists in man. Psychopharmacologia (Berl.) 1973; 28: 121–145
   PubMed Web of Science ®Google Scholar
• Malotte C. J. C., Fielding J. E., Danaher B. G. Description and evaluation of the smoking cessation component of a multiple risk factor intervention program. Public Health Briefs 1981; 71: 844–847
   PubMed Web of Science ®Google Scholar
• MMWR. Smoking and cancer 1982; 31(7)77–80, Reproduced in Bureau of Epidemiology. Texas Morbidity This Week 12(1–3), 1982
   Google Scholar
• MMWR. Smoking and cardiovascular disease 1984; 32(52)677–679
   Google Scholar
• Myrsten A., Elgerot A., Edgren B. Effects of abstinence from tobacco smoking on physiological and psychological arousal levels in habitual smokers. Psy-chosom. Med 1977; 39: 25–38
   PubMed Web of Science ®Google Scholar
• Oster G., Colditz G. A., Kelly N. L. The economic costs of smoking and benefits of quitting for individual smokers. Prev. Med 1984; 13: 377–389
   PubMed Web of Science ®Google Scholar
• Patten B. M. Neuromuscular disease due to tobacco use. Tex. Med 1984; 80: 47–51
   PubMedGoogle Scholar
• Pederson L. L., Scrimgeour W. G., Lefcoe N. M. Variables of hypnosis which are related to success in a smoking withdrawal program. Int. J. Clin. Exp. Hypn 1979; 27: 14–20
   PubMed Web of Science ®Google Scholar
• Pomerleau O., Adkins D., Piertschuk M. Predictors of outcome and recidivism in smoking cessation treatment. Addict. Behav 1978; 3: 65–70
   PubMed Web of Science ®Google Scholar
• Popot J.-L., Changeux J.-P. Nicotine receptor of acetylcholine: Structure of an oligomeric integral membrane protein. Phys. Rev 1984; 64(4)1162–1239
   Web of Science ®Google Scholar
• Ramsdale D. R., Faragher E. B., Bray C. L., Bennett D. H., Ward C., Beton D. C. Smoking and coronary artery disease assessed by routine coronary arteriography. Br. Med. J 1985; 290: 197–200
   PubMed Web of Science ®Google Scholar
• Rosecrans J. A. Nicotine as a discriminative stimulus to behavior: Its characterization and relevance to smoking behavior. Cigarette Smoking as a Dependence Process, N. A. Krasnegor. U.S. Government Printing Office, Washington, DC 1979; 58–69, National Institute on Drug Abuse. Department of Health, Education, and Welfare Publication No. (ADM) 79–800
   Google Scholar
• Russell M. A.H. Cigarette smoking: Natural history of a dependence disorder. Br. J. Med. Psychol 1971; 44(1)1–16
   PubMedGoogle Scholar
• Russell M. A. H., Feyerabend C. Cigarette smoking: A dependence on high-nicotine boli. DrugMetab. Rev 1978; 8: 29–57
   PubMed Web of Science ®Google Scholar
• Weiner N. Neurotransmitter system in the central nervous system. Drugs and the Developing Brain, A. Vernadakis, N. Weiner. Plenum Press, New York 1974; 105–131
   Google Scholar
• Why People Smoke Cigarettes. Publication (PHS) 83–50195, U.S. Department of Health and Human Resources. 1983; 1–5
   Google Scholar
• Wills J. H. Anticholinesterase agents. The International Encyclopedia of Pharmacology and Therapeutics, A. G. Karczmar. Pergamon Press, Oxford 1970; 35–70
   Google Scholar